ES2823589T3 - Formulaciones farmacéuticas para la administración subcutánea de furosemida - Google Patents
Formulaciones farmacéuticas para la administración subcutánea de furosemida Download PDFInfo
- Publication number
- ES2823589T3 ES2823589T3 ES14778339T ES14778339T ES2823589T3 ES 2823589 T3 ES2823589 T3 ES 2823589T3 ES 14778339 T ES14778339 T ES 14778339T ES 14778339 T ES14778339 T ES 14778339T ES 2823589 T3 ES2823589 T3 ES 2823589T3
- Authority
- ES
- Spain
- Prior art keywords
- furosemide
- pharmaceutical formulation
- tris
- liquid pharmaceutical
- hydroxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361808962P | 2013-04-05 | 2013-04-05 | |
| PCT/US2014/032800 WO2014165660A1 (en) | 2013-04-05 | 2014-04-03 | Pharmaceutical formulations for subcutaneous administration of furosemide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2823589T3 true ES2823589T3 (es) | 2021-05-07 |
Family
ID=51659206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14778339T Active ES2823589T3 (es) | 2013-04-05 | 2014-04-03 | Formulaciones farmacéuticas para la administración subcutánea de furosemida |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9884039B2 (OSRAM) |
| EP (2) | EP3799869B1 (OSRAM) |
| JP (2) | JP6415535B2 (OSRAM) |
| KR (2) | KR102266460B1 (OSRAM) |
| CN (1) | CN105431145B (OSRAM) |
| AU (1) | AU2014248164B2 (OSRAM) |
| CA (1) | CA2908935C (OSRAM) |
| DK (1) | DK2981258T3 (OSRAM) |
| ES (1) | ES2823589T3 (OSRAM) |
| IL (1) | IL241917B (OSRAM) |
| MX (1) | MX367165B (OSRAM) |
| PT (1) | PT2981258T (OSRAM) |
| SG (2) | SG11201508251RA (OSRAM) |
| WO (1) | WO2014165660A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9884039B2 (en) | 2013-04-05 | 2018-02-06 | Scpharmaceuticals Inc. | Pharmaceutical formulations for subcutaneous administration of furosemide |
| DE102014115951A1 (de) * | 2014-11-03 | 2016-05-04 | Merlion Pharmaceuticals Pte Ltd. | Zusammensetzungen, die Finafloxacin und Tris enthalten |
| US12403120B2 (en) * | 2018-12-10 | 2025-09-02 | Sq Innovation Ag | Pharmaceutical compositions of furosemide and uses thereof |
| WO2020141224A1 (en) | 2019-01-04 | 2020-07-09 | Sq Innovation Ag | Pharmaceutical compositions of furosemide and uses thereof |
| US12397005B2 (en) | 2019-01-04 | 2025-08-26 | Sq Innovation Ag | Pharmaceutical compositions of torsemide and uses thereof |
| AU2020214314B2 (en) * | 2019-01-31 | 2025-09-18 | Scpharmaceuticals Inc. | Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same |
| WO2022031959A1 (en) * | 2020-08-05 | 2022-02-10 | Scpharmaceuticals Inc. | Methods of treatment using furosemide |
| CA3215872A1 (en) | 2021-04-02 | 2022-10-06 | Scpharmaceuticals Inc. | Subcutaneous infusion of furosemide |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663348A (en) * | 1985-07-02 | 1987-05-05 | Warner-Lambert Co. | Furosemide salts and pharmaceutical preparations thereof |
| US4698361A (en) | 1986-05-28 | 1987-10-06 | Schiena Michele G Di | Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same |
| DE3623620A1 (de) * | 1986-07-12 | 1988-01-21 | Boehringer Mannheim Gmbh | Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung |
| JP3267613B2 (ja) * | 1991-05-30 | 2002-03-18 | アボツト・ラボラトリーズ | イオン捕獲結合アッセイにおける非特異的結合遮断薬を含む試薬 |
| US5633240A (en) | 1994-09-01 | 1997-05-27 | Academic Pharmaceuticals | Parenteral solutions containing metolazone |
| IT1283608B1 (it) * | 1996-04-17 | 1998-04-22 | Ricerche Di Schiena Snc Di Dr | Composizione farmaceutica per la terapia orale diuretica ed antiipertensiva. |
| CN1068778C (zh) | 1998-05-15 | 2001-07-25 | 赵超英 | 救治用的药物组合物及其制备方法 |
| ES2313266T3 (es) | 2005-12-28 | 2009-03-01 | Sensile Pat Ag | Microbomba. |
| AR061980A1 (es) * | 2006-07-12 | 2008-08-10 | Univ Tennessee Res Foundation | Acilanilidas sustituidas y metodos para su utilizacion |
| EP2022518A1 (en) | 2007-08-07 | 2009-02-11 | Sensile Pat AG | Modular drug delivery device for administering discrete doses of a medicament |
| US7923447B2 (en) * | 2008-03-17 | 2011-04-12 | Academic Pharmaceuticals Incorporated | Parenteral solutions containing metolazone |
| CA2724540C (en) | 2008-05-16 | 2014-07-08 | Corthera, Inc. | Treating dyspnea associated with acute heart failure with relaxin |
| CA2735660C (en) * | 2008-09-09 | 2017-05-30 | Cima Labs Inc. | Dosage forms for weakly ionizable compounds |
| EP2473226A1 (en) * | 2009-09-04 | 2012-07-11 | Minipumps LLC | Adhesive skin patch with pump for subcutaneous drug delivery |
| US10849879B2 (en) | 2011-10-19 | 2020-12-01 | Mercator Medsystems, Inc. | Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation |
| US9884039B2 (en) | 2013-04-05 | 2018-02-06 | Scpharmaceuticals Inc. | Pharmaceutical formulations for subcutaneous administration of furosemide |
-
2014
- 2014-04-03 US US14/781,706 patent/US9884039B2/en active Active
- 2014-04-03 EP EP20189271.8A patent/EP3799869B1/en active Active
- 2014-04-03 DK DK14778339.3T patent/DK2981258T3/da active
- 2014-04-03 KR KR1020157031677A patent/KR102266460B1/ko active Active
- 2014-04-03 KR KR1020217018012A patent/KR102493735B1/ko active Active
- 2014-04-03 SG SG11201508251RA patent/SG11201508251RA/en unknown
- 2014-04-03 CA CA2908935A patent/CA2908935C/en active Active
- 2014-04-03 WO PCT/US2014/032800 patent/WO2014165660A1/en not_active Ceased
- 2014-04-03 PT PT147783393T patent/PT2981258T/pt unknown
- 2014-04-03 AU AU2014248164A patent/AU2014248164B2/en active Active
- 2014-04-03 ES ES14778339T patent/ES2823589T3/es active Active
- 2014-04-03 CN CN201480031207.3A patent/CN105431145B/zh active Active
- 2014-04-03 EP EP14778339.3A patent/EP2981258B8/en active Active
- 2014-04-03 SG SG10201709388QA patent/SG10201709388QA/en unknown
- 2014-04-03 MX MX2015014064A patent/MX367165B/es active IP Right Grant
- 2014-04-03 JP JP2016506607A patent/JP6415535B2/ja active Active
-
2015
- 2015-10-06 IL IL241917A patent/IL241917B/en active IP Right Grant
-
2018
- 2018-01-23 US US15/877,865 patent/US10272064B2/en active Active
- 2018-10-02 JP JP2018187299A patent/JP6677779B2/ja active Active
-
2019
- 2019-03-07 US US16/295,085 patent/US11433044B2/en active Active
-
2022
- 2022-08-05 US US17/817,729 patent/US12370168B2/en active Active
-
2025
- 2025-07-16 US US19/271,284 patent/US20250339397A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2823589T3 (es) | Formulaciones farmacéuticas para la administración subcutánea de furosemida | |
| JP6796638B2 (ja) | ヘッジホッグ阻害性化合物の送達のための局所的製剤及びその使用 | |
| CN100569230C (zh) | 含有双氯芬酸钠和β-环糊精的可注射药物组合物 | |
| CN101708157B (zh) | 一种单硝酸异山梨酯氯化钠注射液 | |
| WO2017177160A1 (en) | Formulation for use in a method of treatment of pain | |
| KR101353443B1 (ko) | 데옥시콜린산 나트륨이 없는 포스파티딜콜린 함유 주사제 조성물 및 이의 제조방법 | |
| KR20210150360A (ko) | 푸로세미드의 농축된 액체 제약 제제 및 그의 투여 방법 | |
| US20200338082A1 (en) | Formulations, systems, and methods for therapeutic treatment | |
| CN105566100A (zh) | 一种苯乙烯酸类化合物，包含其的组合物及其应用 | |
| HK40049405A (en) | Pharmaceutical formulations for subcutaneous administration of furosemide | |
| EP4247386A1 (en) | Flumazenil formulations for subcutaneous injection and methods of treatment using gaba receptor modulators | |
| WO2009157010A1 (en) | An intravenous drug delivery system | |
| CN101601653B (zh) | 泼尼卡酯脂质体乳膏 | |
| CA3191276A1 (en) | Ionic liquid formulations for treating diabetes | |
| BR112015025204B1 (pt) | Formulação farmacêutica líquida de furosemida e seu uso | |
| HK1221152B (en) | Pharmaceutical formulations for subcutaneous administration of furosemide | |
| EA046008B1 (ru) | Концентрированные жидкие фармацевтические составы фуросемида и способы их введения | |
| CN104138351A (zh) | 他克莫司非水凝胶 |